1. Home
  2. IONQ vs DVA Comparison

IONQ vs DVA Comparison

Compare IONQ & DVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IONQ
  • DVA
  • Stock Information
  • Founded
  • IONQ 2015
  • DVA 1994
  • Country
  • IONQ United States
  • DVA United States
  • Employees
  • IONQ N/A
  • DVA N/A
  • Industry
  • IONQ Wholesale Distributors
  • DVA Misc Health and Biotechnology Services
  • Sector
  • IONQ Industrials
  • DVA Health Care
  • Exchange
  • IONQ Nasdaq
  • DVA Nasdaq
  • Market Cap
  • IONQ 8.5B
  • DVA 9.7B
  • IPO Year
  • IONQ N/A
  • DVA 1995
  • Fundamental
  • Price
  • IONQ $41.83
  • DVA $137.82
  • Analyst Decision
  • IONQ Strong Buy
  • DVA Hold
  • Analyst Count
  • IONQ 9
  • DVA 2
  • Target Price
  • IONQ $46.78
  • DVA $162.00
  • AVG Volume (30 Days)
  • IONQ 15.6M
  • DVA 719.5K
  • Earning Date
  • IONQ 11-05-2025
  • DVA 10-28-2025
  • Dividend Yield
  • IONQ N/A
  • DVA N/A
  • EPS Growth
  • IONQ N/A
  • DVA 8.72
  • EPS
  • IONQ N/A
  • DVA 10.20
  • Revenue
  • IONQ $52,370,000.00
  • DVA $13,161,328,000.00
  • Revenue This Year
  • IONQ $116.37
  • DVA $5.96
  • Revenue Next Year
  • IONQ $87.06
  • DVA $3.54
  • P/E Ratio
  • IONQ N/A
  • DVA $13.52
  • Revenue Growth
  • IONQ 67.83
  • DVA 5.09
  • 52 Week Low
  • IONQ $6.54
  • DVA $126.07
  • 52 Week High
  • IONQ $54.74
  • DVA $179.60
  • Technical
  • Relative Strength Index (RSI)
  • IONQ 52.17
  • DVA 51.25
  • Support Level
  • IONQ $40.22
  • DVA $135.04
  • Resistance Level
  • IONQ $43.21
  • DVA $137.29
  • Average True Range (ATR)
  • IONQ 2.22
  • DVA 2.88
  • MACD
  • IONQ 0.30
  • DVA 0.26
  • Stochastic Oscillator
  • IONQ 78.79
  • DVA 54.32

About IONQ IonQ Inc.

IonQ Inc sells access to several quantum computers of various qubit capacities and is in the process of researching and developing technologies for quantum computers with increasing computational capabilities. The company currently makes access to its quantum computers available via cloud platforms and also to select customers via its own cloud service. This cloud-based approach enables the broad availability of quantum-computing-as-a-service (QCaaS). The company derives its revenue from its quantum-computing-as-a-service arrangements, consulting services related to co-developing algorithms on company's quantum computing systems, and contracts associated with the design, development, and construction of specialized quantum computing systems together with related services.

About DVA DaVita Inc.

DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business. Berkshire Hathaway owns about 45% of DaVita.

Share on Social Networks: